Coherus BioSciences Inc (CHRS) — Capital Reinvestment Ratio
Coherus BioSciences Inc (CHRS) has a Capital Reinvestment Ratio of 0.02x as of September 2021, meaning it reinvests 0% of its operating cash flow ($13.71 Million) in capital expenditures ($261.00K). Check how tangible is Coherus BioSciences Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Coherus BioSciences Inc Capital Reinvestment Ratio (2013–2020)
This chart tracks Coherus BioSciences Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see CHRS operating cash flow.
Annual Capital Reinvestment Ratio for Coherus BioSciences Inc (2013–2020)
Year-by-year Capital Reinvestment Ratio for Coherus BioSciences Inc from 2013 to 2020. See CHRS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $154.15 Million | $7.23 Million | ▼ -89.7% |
| 2019 | 0.45x | $28.36 Million | $12.90 Million | ▲ +1780.7% |
| 2013 | 0.02x | $15.42 Million | $373.00K | — |